Bristol-Myers Squibb sees stabilizing sales, growth in key drugs, and raised guidance. Click to read more about why BMY is an ...

Introduction Medication-related problems at transitions of care are ... in any one individual study (avoiding excessive burden on study participants, type 1 errors in interpreting results). The ...

Improvements in traditional medications and surgical techniques have helped, yet issues, including medication side effects and extended ... Integration of trial sequential analysis to control random ...